In an open letter, Pfizer CEO Albert Bourla is making the case for his company's vaccine booster shot, one day before an FDA advisory committee meets to debate and vote on the issue.
Bourla underscored the "strong immune response after the booster dose" and vowed that Pfizer has "stayed true to our commitment of full transparency without selectively cherry-picking data."
"Some people and organizations have raised concerns that the approval of boosters will divert doses dedicated to the low- and middle-income countries and redirect them to the high-income countries. And they use this argument to claim that boosters should not be approved. I disagree," Bourla wrote.
"No commitments already made by Pfizer to a country will change if boosters are approved," he wrote.
Cashin in isn't it? Just a thought.
No comments:
Post a Comment